ALT: Altimmune, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 650.08
Enterprise Value ($M) 618.61
Book Value ($M) 133.38
Book Value / Share 1.88
Price / Book 4.87
NCAV ($M) 131.27
NCAV / Share 1.85
Price / NCAV 4.95

Profitability (mra)
Return on Invested Capital (ROIC) -0.77
Return on Assets (ROA) -0.62
Return on Equity (ROE) -0.69

Liquidity (mrq)
Quick Ratio 16.87
Current Ratio 16.87

Balance Sheet (mrq) ($M)
Current Assets 145.76
Assets 147.86
Liabilities 14.49
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Ameriprise Financial Inc 5.45 -7.35
10-17 13G/A State Street Corp 4.80 -12.67
10-16 13G/A Millennium Management Llc 0.20 -95.05
02-14 13G/A Nuveen Asset Management, LLC 2.88
02-14 13G/A Teachers Advisors, Llc 2.88
02-14 13G/A Tiaa Cref Investment Management Llc 2.88 -47.11
02-14 13G/A Avidity Partners Management LP 0.00 -100.00
02-14 13G/A Tang Capital Partners Lp 5.10 1.83
02-13 13G/A Vanguard Group Inc 6.65 41.05
02-12 13G/A Janus Henderson Group Plc 0.00 -99.99
01-26 13G BlackRock, Inc. 7.50 320.37

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-12-06 620,340 3,090,226 20.07
2024-12-05 1,046,060 4,361,720 23.98
2024-12-04 2,021,338 10,585,999 19.09
2024-12-03 713,606 3,439,447 20.75

(click for more detail)

Similar Companies
ACRV – Acrivon Therapeutics, Inc. ADMA – ADMA Biologics, Inc.
AFMD – Affimed N.V. ANIP – ANI Pharmaceuticals, Inc.
APGE – Apogee Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io